Search
for
Sort by
Research 391–420 of 1000+
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- mTOR signaling in hair follicle and hair diseases: recent progress
- 원형탈모증(alopecia areata)의 최신 이해와 치료
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Alopecia Areata: An Updated Review for 2023
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Resident Memory T Cells in Autoimmune Skin Diseases
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Topical Delivery of Tofacitinib in Dermatology: The Promise of a Novel Therapeutic Class Using Biodegradable Dendritic Polyglycerol Sulfates
- Stem cell-based therapies for alopecia areata: a narrative review
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Baricitinib as a treatment for myasthenia gravis: A case report
- CXCL12 inhibits hair growth through CXCR4
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Alopecia Areata: Current Treatments and New Directions
- Treatment of pediatric alopecia areata: A systematic review
- New and Emerging Therapies for Alopecia Areata
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Parsing patterns: Emerging roles of tissue self-organization in health and disease